JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.04B |
| 2 |
Truist Financial
TFC
|
+$964M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$909M |
| 4 |
Texas Instruments
TXN
|
+$800M |
| 5 |
Johnson & Johnson
JNJ
|
+$783M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.43B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$1.21B |
| 3 |
STI
SunTrust Banks, Inc.
STI
|
+$987M |
| 4 |
Microsoft
MSFT
|
+$980M |
| 5 |
CELG
Celgene Corp
CELG
|
+$929M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.95% |
| 2 | Financials | 11.95% |
| 3 | Healthcare | 9.46% |
| 4 | Consumer Discretionary | 8.62% |
| 5 | Industrials | 6.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3976
CALL
Fluor
FLR
$6.96B
| $604K | ﹤0.01% |
32,000
| – | – |
|
|
ANAT
3977
DELISTED
American National Group, Inc. Common Stock
ANAT
| $603K | ﹤0.01% |
5,125
+1,787
| +54% | +$211K |
|
3978
Goldgroup Mining Inc.
GORO
$211M
| $602K | ﹤0.01% |
108,683
-271,651
| -71% | -$1.19M |
|
3979
iShares US Consumer Staples ETF
IYK
$1.42B
| $602K | ﹤0.01% |
13,554
-372
| -3% | -$15.9K |
|
|
BSTC
3980
DELISTED
BioSpecifics Technologies Corp.
BSTC
| $601K | ﹤0.01% |
10,554
-9,317
| -47% | -$494K |
|
3981
Philips
PHG
$26.2B
| $598K | ﹤0.01% |
15,442
+4,142
| +37% | +$150K |
|
|
PZN
3982
DELISTED
Pzena Investment Management, Inc. Class A
PZN
| $598K | ﹤0.01% |
69,434
+14,307
| +26% | +$123K |
|
|
ALLK
3983
DELISTED
Allakos
ALLK
| $597K | ﹤0.01% |
6,264
-121
| -2% | -$10.6K |
|
3984
CALL
Sanofi
SNY
$105B
| $597K | ﹤0.01% |
+11,900
| New | +$557K |
|
3985
ImmunityBio
IBRX
$8.2B
| $596K | ﹤0.01% |
157,245
+30,604
| +24% | +$52.1K |
|
3986
PRA Group
PRAA
$737M
| $596K | ﹤0.01% |
16,413
+243
| +2% | +$8.61K |
|
3987
CALL
Centene
CNC
$33.1B
| $591K | ﹤0.01% |
+9,400
| New | +$510K |
|
3988
Tactile Systems Technology
TCMD
$555M
| $591K | ﹤0.01% |
8,757
-8,309
| -49% | -$460K |
|
3989
Digimarc Corp
DMRC
$167M
| $590K | ﹤0.01% |
17,566
-7,885
| -31% | -$283K |
|
|
BLU
3990
DELISTED
BELLUS Health Inc.
BLU
| $590K | ﹤0.01% |
77,594
+15,000
| +24% | +$103K |
|
3991
Invesco Solar ETF
TAN
$1.37B
| $586K | ﹤0.01% |
19,015
-7,806
| -29% | -$226K |
|
3992
iShares US Consumer Discretionary ETF
IYC
$1.21B
| $584K | ﹤0.01% |
10,236
-1,392
| -12% | -$77.3K |
|
3993
iShares US Pharmaceuticals ETF
IHE
$1.65B
| $582K | ﹤0.01% |
10,902
-3,687
| -25% | -$182K |
|
3994
Metropolitan Bank Holding Corp
MCB
$1.17B
| $579K | ﹤0.01% |
11,994
+6,769
| +130% | +$299K |
|
3995
Cohen & Steers Duration Preferred & Income Fund
LDP
$599M
| $577K | ﹤0.01% |
22,015
+278
| +1% | +$7.23K |
|
|
BPYU
3996
DELISTED
Brookfield Property REIT Inc. Class A Common Stock
BPYU
| $575K | ﹤0.01% |
31,207
-76,985
| -71% | -$1.46M |
|
3997
Bankwell Financial Group
BWFG
$542M
| $573K | ﹤0.01% |
19,889
+5,860
| +42% | +$167K |
|
|
CHNG
3998
DELISTED
Change Healthcare Inc. Common Stock
CHNG
| $573K | ﹤0.01% |
34,935
+27,124
| +347% | +$364K |
|
|
PMBC
3999
DELISTED
Pacific Mercantile Bancorp
PMBC
| $572K | ﹤0.01% |
70,408
-46,544
| -40% | -$341K |
|
4000
Byline Bancorp
BY
$1.78B
| $570K | ﹤0.01% |
29,156
+21,518
| +282% | +$393K |
|
Similar funds
JP Morgan Chase's Q4 2019 Portfolio in Review
As of Q4 2019, JP Morgan Chase held 6,136 positions worth $536B, up 6.8% from $502B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q4 2019 filing shows 374 new, 2,295 increased, 2,258 reduced and 490 closed positions. Its largest new stake was XP: 4,912,590 shares worth $189M. The largest sale was Pfizer, an estimated $1.43B.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.
- JP Morgan Chase's largest Q4 2019 buy was XP: 4,912,590 shares worth $189M.
- JP Morgan Chase added most to iShares 20+ Year Treasury Bond ETF in Q4 2019, an estimated $1.04B increase.
- JP Morgan Chase's biggest Q4 2019 reduction was Pfizer, cutting an estimated $1.43B.
- JP Morgan Chase fully exited SunTrust Banks, Inc. in Q4 2019, selling an estimated $987M.
- JP Morgan Chase's ten largest holdings make up 17% of its $536B portfolio in Q4 2019.
- JP Morgan Chase opened 374 new positions and closed 490 in Q4 2019.
- JP Morgan Chase's portfolio value rose 6.8% quarter-over-quarter to $536B.
Based on JP Morgan Chase's 13F filing for Q4 2019, filed 11 Feb 2020.